Objective. To assess dermal expression and fibroblast production of fibrillin-1 (FBN-1) in SSc.
Introduction
Fibrosis is a hallmark of SSc. The fibrosis corresponds to massive deposits of extracellular matrix (ECM) substances such as collagen [1] . Microfibrillar network displays a structural role in the tissue-specific organization of ECM. Fibrillin-1 (FBN-1) is the main component of the 10-12 nm ECM microfibrils [2] .
Numerous data support the role of FBN-1 in SSc: (i) the tight skin 1 (Tsk1/+) mouse results in a partial in-frame duplication of FBN-1 and develops a thickened and abnormally structured dermis and is a widely used model for studying SSc [3] ; (ii) FBN-1 auto-antibodies have been described in SSc and are suspected to induce a profibrotic phenotype in fibroblasts [4] ; and (iii) FBN-1 microfibril abnormalities have been reported in SSc but with conflicting results [5, 6] . Fleischmajer showed an in vivo increased amount of microfibrils in the lower dermis of SSc patients [5] , whereas in vitro metabolic labelling studies have suggested a defect of FBN-1-containing microfibrils due to excessive instability [6] .
Moreover, several association studies raise the question of the implication of FBN1 gene polymorphisms in genetic susceptibility to SSc in particular in Choctaw Indians [7] . However, in a recent study [8] , we found no significant association between FBN1 gene polymorphisms and the disease in a large cohort of European Caucasian SSc patients.
Besides, it is now accepted that ECM is involved in the regulation of various cytokines and growth factors among which TGF-b is the prototypic profibrotic cytokine [9] . Altogether, these data suggest that FBN-1 defects contribute to SSc but we hypothesized that this potential role could not be through FBN1 gene susceptibility. Thus, we investigated whether expression and production of FBN-1 could be altered in the dermis of SSc patients.
Patients and methods

Patients
SSc patients were recruited in the Rheumatology A Department of Cochin University Hospital. All patients had a disease duration of <5 years since the first non-Raynaud symptom and a cutaneous diffuse form according to LeRoy's criteria [10] . The skin status (affected and unaffected) was clinically evaluated by two clinicians (J.W. and Y.A.). Ethical approval for this study was obtained from CCPPRB Paris-Cochin. All the patients gave written informed consent for participating in the study.
Electron microscopy
Biopsies for EM were performed from clinically affected and non-affected skin of SSc patients and healthy controls who were matched for age and site of biopsy. Ultrafine sections, enclosed in Epon, had been stained by uranyl acetate and lead citrate. Visualization was performed at 40 000Â using an electron microscope (Zeiss Le Pecq, France).
Cell cultures
Dermal fibroblasts were explanted from skin biopsy pairs from six SSc and four Marfan syndrome (MFS) patients and from five healthy controls. All SSc patients had systemically one biopsy each in clinically affected and unaffected areas of skin. The healthy controls were matched for age and site of biopsy (forearm area for lesional skin and upper part of the arm for unaffected skin). Fibroblasts were stored in liquid nitrogen (À196 C) and were used at passages 2-8.
Immunofluorescence
Fibroblasts (250 000 cells/well) were placed into four-well tissue culture Lab-Tek slides (Permanox; Nunc, Rochester, NY, USA). After 24 h, the medium was replaced by fetal calf serum free DMEM with or without TGF-b at 10 ng/ml (R&D Systems Europe, Lille, France).
After 5 or 6 days, the samples were incubated with primary antibody to FBN-1 (clone 11C1.3; Lab Vision Corporation, Fremont, CA, USA) and were subsequently exposed for 1 h at 37 C with a Alexa Fluor 488 F(ab 0 )2 fragment of goat anti-mouse IgG (H + L) (Invitrogen, Paisley, UK). After nuclei counterstaining with propidium iodide, visualization was performed with confocal Zeiss LSM 5 Pascal microscopy.
Western blot
At the confluence of fibroblasts, culture medium was eliminated and serum-free DMEM was added with or without TGF-b (10 ng/ml) for 6 days. ECM proteins were extracted from cell lysates and were equally loaded into each lane of an SDS-PAGE gel (Invitrogen, Carlsbad, CA, USA). After transfer, nitrocellulose membranes (Amersham Biosciences, Piscataway, NJ, USA) were probed with primary antibody mouse monoclonal anti-FBN-1 (clone 11C1.3), and then with the corresponding secondary antibody (goat anti-mouse; Amersham Biosciences, Buckinghamshire, UK). The membranes were reprobed with actin antibody (Santa Cruz, CA, USA) to correct loading differences and efficiency in electrophoretic transfer.
Gene expression assays
Total mRNA was obtained using the RNeasy Mini Extraction Kit (Qiagen, Courtaboeuf, France). Gene expression assays were performed in triplicate as previously described [11] with primer sequences (Applied Biosystems, Courtaboeuf, France) for the FBN1 (Hs00171191_ m1) and the GAPDH gene (Hs99999905_m1), the housekeeping control gene. Results were the average of triplicate assays and were expressed in expression arbitrary units (EAUs) of FBN1 gene normalized with respect to the GAPDH gene.
Statistical analysis
Gene expression assays are presented as EAU (S.E.M.). Comparison between any two groups was by unpaired t-test for normally distributed data. P < 0.05 was considered statistically significant.
Results
Electron microscopy
EM results are shown in Fig. 1 . EM analysis (40 000Â) focused on the microfibrillar network surrounding the elastic fibres but collagen fibres were also visualized. The 'bead-on-a-string' appearance of the microfibrils cannot be visualized because rotary shadowed microscopy was not available and electron microscopic magnification was not sufficient. Thus, analysis was restricted to the aspect of microfibrils excluding abnormalities of morphology. The comparison of EM images between control and SSc patients showed that, in vivo, elastin-associated microfibrillar network appeared to be thicker in controls than in SSc. When comparing the dermal SSc elastic and collagen fibres with controls, no difference was detected. In SSc patients, affected and unaffected skin provided globally similar aspect of microfibrils, both showing a decrease.
Immunofluorescence
Without TGF-b activation, the classical IF microscopy aspect is similar between healthy controls and SSc: there are a few fluorescent linear stripes that are absent in MFS controls (data not shown). These results were magnified and confirmed by confocal microscopy (Fig. 2) .
After TGF-b exposure, although the number of fibroblasts did not seem to be different, there was a densification and an organization of the microfibrillar network in particular in fibroblast clusters (Fig. 2) . The enhanced structuring after TGF-b activation was similar between microfibrils from affected or unaffected SSc skin and controls. The MFS controls showed an absence of established microfibrillar network after TGF-b activation (Fig. 2) . Thus, SSc and healthy fibroblasts not only provided the same IF profile in TGF-b-free medium, but also were influenced in the same way by TGF-b activation: indeed there was no altered response to TGF-b activation by SSc fibroblasts compared with normal controls.
Western blot
The amounts of FBN-1 were evaluated by western blot (WB) of matrix protein from cell lysates of cultured dermal fibroblasts after scraping cells onto dishes. Without TGF-b, fibroblasts from affected and unaffected SSc skin synthesized and secreted equivalent amounts of FBN-1 compared with controls (Fig. 2) . The FBN1-mutated Marfan fibroblasts secreted a similar FBN-1 amount to that of the two others. As expected, TGF-b activation increased FBN-1 amounts in the same proportion for controls and SSc from fibroblast cultures of affected or unaffected SSc skin. Marfan fibroblasts responded in the same way to TGF-b induction.
Semi-quantitative analysis from WB was performed using Image J software. The results confirmed the absence of difference between FBN-1 amounts in SSc fibroblast cultures from unaffected and affected skin; in healthy controls (data not shown) without and with TGF-b; and in Marfan with a density of FBN-1 protein after TGF-b activation 2.44-, 1.77-, 1.54-and 2.11-fold, respectively.
Gene expression analysis
We postulated that increased gene expression could explain the activation of the in vitro organization of FBN-1-containing microfibrils in matrix by TGF-b in SSc and controls and the concomitant increased matricial amounts of FBN-1. To test this hypothesis, gene expression assays by real-time PCR were performed from fibroblast cultures with or without 48 h of TGF-b activation. At basal state and without TGF-b activation, amounts of FBN-1 mRNA were similar between healthy controls and SSc samples for unaffected skin and affected skin (data not shown). Furthermore, results showed that there was no significant enhancement of FBN1 gene expression in controls and SSc patients after TGF-b activation. When comparing potential enhancement between controls and SSc, there was no statistical difference.
Discussion
Our results show that (i) there is a striking decrease of in vivo elastin-associated microfibrillar network in nonaffected and affected SSc skin compared with healthy controls; and (ii) this alteration is not due to deficient production, secretion and organization of FBN-1 and microfibrils by SSc dermal fibroblasts.
EM results demonstrated that, in vivo, the microfibrillar network associated with elastin appears to be reduced compared with healthy controls in SSc dermal biopsies. Furthermore, this reduction was also present in unaffected skin of these dcSScs, which are able to develop cutaneous fibrosis. This suggests that the histological alteration of microfibrils in SSc could precede clinical involvement. This in vivo result should be put in perspective with the fact that the capacity of SSc dermal fibroblasts to produce and organize a meshwork of microfibrils in vitro is intact at basal state i.e. without TGF-b activation. These results could reveal that in vivo histological abnormalities of the microfibrillar network occur at an early stage of SSc, precede clinical skin fibrosis and thus may be one of the factors participating in the secondary establishment of fibrosis. The observed microfibrillar abnormalities are probably a secondary event of matrix deregulation inherent in SSc.
Kikuchi et al. [12] have raised the hypothesis of a higher sensitivity of SSc fibroblasts to TGF-b activation in   FIG. 1 Electron microscopic localization of microfibrils. Visualization was performed at 40 000Â after staining by uranyl acetate and lead citrate. In healthy control skin, microfibrillar network (red arrow) surrounds elastic fibres (black arrow) with puny aspect. Collagen fibres are also indicated (white arrow). In unaffected skin of SSc patients, microfibrils seem to be quantitatively diminished compared with controls. In SSc-affected skin, the microfibrillar network seems to be not different from that seen in the unaffected one.
www.rheumatology.oxfordjournals.org particular for growth regulation. Our IF results suggest that the role of TGF-b in microfibrillar network organization seems unaffected in SSc as compared with healthy controls. Secondly, the WB results suggest that the intrinsic behaviour of SSc fibroblasts in culture with or without TGF-b is similar between SSc and controls. Our results are in accordance with a previous study [13] . To go further, real-time PCR results confirmed previous published northern blot results [13] Another matter of debate relates to the difference of phenotype between fibroblasts from affected and non-affected areas of the SSc skin in published results. In our study, investigations from involved and uninvolved dermis fibroblasts did not detect any behaviour difference. Currently, opinions are divided on this topic: some authors support the hypothesis that fibroblasts from non-affected areas of dcSSc skin samples have the same pre-clinical activation phenotype as that of the involved skin [14, 15] ; conversely, others describe differences [16, 17] . Therefore, it remains undefined whether fibroblasts from affected or non-affected SSc skin share an identical phenotype.
Finally, some authors think that the biological relationship between FBN-1 and TGF-b in the fibrillinopathies, of which SSc is one, seems to be an abnormal activation of the TGF-b pathway [18] . The main hypothesis, taking into account the abnormalities of the microfibrillar network and TGF-b signalling in SSc, might lie in abnormal proteolysis of FBN-1-containing microfibrillar network with the following sequence of events: normal interaction between FBN-1 and TGF-b but inadequate proteolysis of microfillar network with excessive secondary activation of TGF-b and its effectors. This hypothesis might be in accordance with recent published data showing abnormal MMP1 levels in supernatants of reconstructed dermis with fibroblasts from lesional late-stage SSc patients [19] . Investigations of these aspects of the pathogenesis of fibrosis are ongoing.
Conclusions
The in vivo quantitative decrease of the microfibrillar network in both clinically affected and unaffected SSc skin appears not to be due to a deficiency of SSc fibroblast FBN-1 synthesis, secretion and microfibrillar assembly. Our results observed in SSc suggest that disturbances of the microfibrillar network are probably a secondary event to matrix deregulation inherent to SSc, which may be inadequate proteolysis of the microfibrillar network leading to excessive release of TGF-b, in turn leading to fibrosis .   FIG. 2 Evaluation of the synthesis, secretion and organization of FBN-1 by fibroblasts without and with TGF-b (10 ng/ml) activation in controls, SSc and Marfan using confocal IF of the FBN-1 microfibrillar network in fibroblast culture stained for FBN-1 with FITC (green) and nuclei stained with propidium iodide reagent (red) and WB of FBN-1 protein (with semi-quantitative analysis performed using Image J software) extracted from ECM of fibroblast culture. Results show induction of FBN-1 matrix accumulation in dermal fibroblast culture by TGF-b in a similar way between SSc and controls.
Rheumatology key messages
. SSc patients show a striking decrease in the in vivo microfibrillar network in affected and unaffected skin. . In vitro production, secretion and organization of microfibrils by SSc fibroblasts are normal.
